Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases. (Q31148353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Marcelo R Bonomi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alfredo H Navigante

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Monica A Castro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Maria E Cabalar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Berta M C Roth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

73-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719279%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-004-9179-x

8 January 2020

exact match

0 references

cites work

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

1 reference

12 December 2020

Brain metastases: treatment options to improve outcomes

1 reference

12 December 2020

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

1 reference

12 December 2020

The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities

1 reference

12 December 2020

Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?

1 reference

12 December 2020

Corticosteroid toxicity in neuro-oncology patients

1 reference

12 December 2020

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations

1 reference

12 December 2020

Epidemiology of brain tumors: the national survey of intracranial neoplasms

1 reference

12 December 2020

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

1 reference

12 December 2020

Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease

1 reference

12 December 2020

On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs

1 reference

12 December 2020

Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

1 reference

12 December 2020

High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

1 reference

12 December 2020

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

12 December 2020

The complications of high-dose corticosteroid therapy in neurosurgical patients: a prospective study

1 reference

12 December 2020

Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts

1 reference

12 December 2020

Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

1 reference

12 December 2020

Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.

1 reference

12 December 2020

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases

1 reference

12 December 2020

Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor

1 reference

12 December 2020

Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody

1 reference

12 December 2020

Increase in radioresponse of murine tumors by treatment with indomethacin

1 reference

12 December 2020

Characterization of the effects of antiangiogenic agents on tumor pathophysiology

1 reference

12 December 2020

Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury

1 reference

12 December 2020

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

12 December 2020

Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence

1 reference

12 December 2020

Expression of cyclooxygenase 2 in human malignant melanoma.

1 reference

12 December 2020

Eicosanoids and radiation

1 reference

12 December 2020

A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas

1 reference

12 December 2020

Simultaneous determination of celecoxib, hydroxycelecoxib, and carboxycelecoxib in human plasma using gradient reversed-phase liquid chromatography with ultraviolet absorbance detection

1 reference

12 December 2020

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

1 reference

12 December 2020

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

12 December 2020

Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis

1 reference

12 December 2020

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human lung carcinoma

1 reference

12 December 2020

Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide

1 reference

12 December 2020

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

1 reference

12 December 2020

Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.

1 reference

12 December 2020

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme

1 reference

12 December 2020

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

1 reference

12 December 2020

Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models

1 reference

12 December 2020

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases

1 reference

12 December 2020

Corticosteroid therapy in patients with brain tumors

1 reference

12 December 2020

Cyclooxygenase-2 expression in colorectal cancer liver metastases.

1 reference

12 December 2020

High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy.

1 reference

12 December 2020

Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers

1 reference

12 December 2020

Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor

1 reference

12 December 2020